Search

everythinglearnresearchcommunity

for

Search:↓

Regular monitoring of autoantibodies in ANA-positive patients with hair loss helps detect and treat lupus early.

The patient with both scarring and non-scarring hair loss showed complex immune reactions and improved with steroid treatment.

Metformin and liraglutide improved symptoms of HAIR-AN syndrome in a child.

Hidradenitis Suppurativa has genetic links, with certain gene mutations more common in patients and a third of cases having a family history.

A 21-year-old male with a rare genetic disorder experienced sudden hair loss and high DHEAS levels, likely due to a condition similar to PCOS, usually seen in women.

Cortisone tapering may help improve severe myasthenia gravis and alopecia areata after thymectomy.

Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.

Sex and race affect immune responses and treatment outcomes in Hidradenitis suppurativa.

Localized hair growth and fat loss may share a common cause in lupus panniculitis.

Alopecia areata patients may have higher T3 and cortisol levels, suggesting a hormonal link.

Children with alopecia areata have immune imbalances and are more likely to have certain health issues.

Unregulated glucocorticoid use can disrupt hormone balance and cause serious health issues.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Vitiligo and alopecia areata may share common causes.

Plasmacytoid dendritic cells, which overproduce IFN-α, may play a crucial role in starting alopecia areata, an autoimmune disease causing hair loss.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

Turner's syndrome may be linked to autoimmune diseases like psoriasis and alopecia areata, needing comprehensive care.

Mutations in the NR3C1 gene cause a rare condition that affects hormone signaling and can lead to various symptoms, with dexamethasone as a treatment option.

Elevated granulysin levels may indicate disease activity in vitiligo and alopecia areata.

Most hirsutism patients had idiopathic hirsutism or PCOS, with hormonal imbalances and signs like acne and irregular periods.

The woman was diagnosed with lichen sclerosus, a rare skin condition, after initial misdiagnosis and ineffective treatments.

Alopecia areata patients have fewer protective regulatory B cells, which may contribute to the disease.

The conclusion is that a new method could improve the identification of autoimmune targets in alopecia areata, despite some limitations.

Alopecia areata and vitiligo can coexist, respond well to treatment, and may have a better prognosis together.

Tildrakizumab significantly improved recalcitrant lichen planopilaris and frontal fibrosing alopecia.

Vitiligo patients often have other health issues, especially thyroid disorders.

Early diagnosis and targeted anti-inflammatory treatments can improve outcomes in androgenetic alopecia with perifollicular inflammation and fibrosis.

Celiac disease can cause thyroid medication malabsorption, and a gluten-free diet can help stabilize thyroid levels.

IL-17 plays a key role in severe hair loss in chronic alopecia areata.